Your browser doesn't support javascript.
loading
The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients' Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers.
Jun, Soo Young; Yoon, Hyang Ran; Yoon, Ji-Yong; Jeon, Su-Jin; Lee, Jeong-Ju; Halder, Debasish; Kim, Jin-Man; Kim, Nam-Soon.
Afiliação
  • Jun SY; Medical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
  • Yoon HR; Rare-Disease Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
  • Yoon JY; Department of Functional Genomics, University of Science & Technology, Daejeon 34113, Korea.
  • Jeon SJ; Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
  • Lee JJ; Medical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
  • Halder D; Rare-Disease Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
  • Kim JM; Medical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
  • Kim NS; Rare-Disease Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon 34141, Korea.
Cancers (Basel) ; 13(12)2021 Jun 11.
Article em En | MEDLINE | ID: mdl-34208132
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article